Reference ranges and determinants of total hCG levels during pregnancy: the Generation R Study

European Journal of Epidemiology

Volumn 30, Issue 9, 2015, Pages 1057-1066

  Korevaar, Tim I M ^a   Steegers, Eric A P ^b   de Rijke, Yolanda B ^a,b   Schalekamp Timmermans, Sarah ^a,b   Visser, W Edward ^a   Hofman, Albert ^a   Jaddoe, Vincent W V ^a,b   Tiemeier, Henning ^a,b   Visser, Theo J ^a   Medici, Marco ^a   Peeters, Robin P ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

Determinants; hCG; Pregnancy; Reference range

Indexed keywords

CHORIONIC GONADOTROPIN; BIOLOGICAL MARKER; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ARTICLE; BODY MASS; EMBRYO GROWTH; ETHNICITY; FEMALE; FETUS ECHOGRAPHY; GENDER; GESTATIONAL AGE; HORMONE BLOOD LEVEL; HUMAN; HYPEREMESIS GRAVIDARUM; MAJOR CLINICAL STUDY; MATERNAL SMOKING; MENSTRUAL CYCLE; PARITY; PLACENTA WEIGHT; PREGNANCY; PREGNANT WOMAN; REFERENCE VALUE; ADULT; BLOOD; NETHERLANDS; PLACENTA; PRENATAL DIAGNOSIS; PROSPECTIVE STUDY; SOCIOECONOMICS;

ADULT; BIOMARKERS; BODY MASS INDEX; CHORIONIC GONADOTROPIN; FEMALE; GESTATIONAL AGE; HUMANS; NETHERLANDS; PLACENTA; PREGNANCY; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PRENATAL DIAGNOSIS; PROSPECTIVE STUDIES; REFERENCE VALUES; SOCIOECONOMIC FACTORS;

EID: 84942552752     PISSN: 03932990     EISSN: 15737284     Source Type: Journal    
DOI: 10.1007/s10654-015-0039-0     Document Type: Article

References (46)

1. Strott CA, Yoshimi T, Ross GT, Lipsett MB. Ovarian physiology: relationship between plasma LH and steroidogenesis by the follicle and corpus luteum; effect of HCG. J Clin Endocrinol Metab. 1969;29(9):1157–67.
2. Aschheim S, Zondek B. Das Hormon des hypophysenvorderlappens: testobjekt zum Nachweis des hormons. Klin Wochenschr. 1927;6:248–52.
3. Lenton EA, Neal LM, Sulaiman R. Plasma concentrations of human chorionic gonadotropin from the time of implantation until the second week of pregnancy. Fertil Steril. 1982;37(6):773–8.
4. Cole LA. Biological functions of hCG and hCG-related molecules. Reprod Biol Endocrinol. 2010;8:102. doi:10.1186/1477-7827-8-102.
5. Kirkegaard I, Uldbjerg N, Petersen OB, Torring N, Henriksen TB. PAPP-A, free beta-hCG, and early fetal growth identify two pathways leading to preterm delivery. Prenat Diagn. 2010;30(10):956–63. doi:10.1002/pd.2593.
6. Olsen RN, Woelkers D, Dunsmoor-Su R, Lacoursiere DY. Abnormal second-trimester serum analytes are more predictive of preterm preeclampsia. Am J Obstet Gynecol. 2012;207(3):228 e1-7. doi:10.1016/j.ajog.2012.06.006.
7. Goetzl L, Krantz D, Simpson JL, et al. Pregnancy-associated plasma protein A, free beta-hCG, nuchal translucency, and risk of pregnancy loss. Obstet Gynecol. 2004;104(1):30–6. doi:10.1097/01.AOG.0000129969.78308.4f.
8. Chandra S, Scott H, Dodds L, Watts C, Blight C, Van Den Hof M. Unexplained elevated maternal serum alpha-fetoprotein and/or human chorionic gonadotropin and the risk of adverse outcomes. Am J Obstet Gynecol. 2003;189(3):775–81.
9. Spencer K. Second-trimester prenatal screening for Down syndrome and the relationship of maternal serum biochemical markers to pregnancy complications with adverse outcome. Prenat Diagn. 2000;20(8):652–6. doi:10.1002/1097-0223(200008)20:8<652:AID-PD882>3.0.CO;2-6.
10. Dugoff L, Hobbins JC, Malone FD, et al. Quad screen as a predictor of adverse pregnancy outcome. Obstet Gynecol. 2005;106(2):260–7. doi:10.1097/01.AOG.0000172419.37410.eb.
11. Larsen J, Buchanan P, Johnson S, Godbert S, Zinaman M. Human chorionic gonadotropin as a measure of pregnancy duration. Int J Gynecol Obstet. 2013;123(3):189–95. doi:10.1016/j.ijgo.2013.05.028.
12. Cole LA, Sutton JM, Higgins TN, Cembrowski GS. Between-method variation in human chorionic gonadotropin test results. Clin Chem. 2004;50(5):874–82. doi:10.1373/clinchem.2003.026989.
13. Mahendru AA, Daemen A, Everett TR, et al. Impact of ovulation and implantation timing on first-trimester crown-rump length and gestational age. Ultrasound Obstet Gynecol. 2012;40(6):630–5. doi:10.1002/uog.12277.
14. Bock JL. HCG assays. A plea for uniformity. Am J Clin Pathol. 1990;93(3):432–3.
15. Cole LA, Shahabi S, Butler SA, et al. Utility of commonly used commercial human chorionic gonadotropin immunoassays in the diagnosis and management of trophoblastic diseases. Clin Chem. 2001;47(2):308–15.
16. Zhang J, Lambert-Messerlian G, Palomaki GE, Canick JA. Impact of smoking on maternal serum markers and prenatal screening in the first and second trimesters. Prenat Diagn. 2011;31(6):583–8. doi:10.1002/pd.2755.
17. Tislaric D, Brajenovic-Milic B, Ristic S, et al. The influence of smoking and parity on serum markers for Down’s syndrome screening. Fetal Diagn Ther. 2002;17(1):17–21.
18. Eskild A, Fedorcsak P, Morkrid L, Tanbo TG. Maternal body mass index and serum concentrations of human chorionic gonadotropin in very early pregnancy. Fertil Steril. 2012;98(4):905–10. doi:10.1016/j.fertnstert.2012.06.011.
19. Neveux LM, Palomaki GE, Larrivee DA, Knight GJ, Haddow JE. Refinements in managing maternal weight adjustment for interpreting prenatal screening results. Prenat Diagn. 1996;16(12):1115–9. doi:10.1002/(SICI)1097-0223(199612)16:12<1115:AID-PD3>3.0.CO;2-6.
20. Yaron Y, Wolman I, Kupferminc MJ, Ochshorn Y, Many A, Orr-Urtreger A. Effect of fetal gender on first trimester markers and on Down syndrome screening. Prenat Diagn. 2001;21(12):1027–30.
21. Watt HC, Wald NJ, Smith D, Kennard A, Densem J. Effect of allowing for ethnic group in prenatal screening for Down’s syndrome. Prenat Diagn. 1996;16(8):691–8. doi:10.1002/(SICI)1097-0223(199608)16:8<691:AID-PD946>3.0.CO;2-2.
22. Roland MC, Friis CM, Godang K, Bollerslev J, Haugen G, Henriksen T. Maternal factors associated with fetal growth and birthweight are independent determinants of placental weight and exhibit differential effects by fetal sex. PLoS One. 2014;9(2):e87303. doi:10.1371/journal.pone.0087303.
23. Vandraas KF, Vikanes AV, Vangen S, Magnus P, Stoer NC, Grjibovski AM. Hyperemesis gravidarum and birth outcomes-a population-based cohort study of 2.2 million births in the Norwegian Birth Registry. BJOG. 2013;120(13):1654–60. doi:10.1111/1471-0528.12429.
24. Jaddoe VW, van Duijn CM, Franco OH, et al. The Generation R Study: design and cohort update 2012. Eur J Epidemiol. 2012;27(9):739–56. doi:10.1007/s10654-012-9735-1.
25. Cole LA. The hCG assay or pregnancy test. Clin Chem Lab Med. 2012;50(4):617–30. doi:10.1515/Cclm.2011.808.
26. Cole LA. Human Chorionic Gonadotropin (hCG). Amsterdam: Elsevier; 2014.
27. Verburg BO, Steegers EA, De Ridder M, et al. New charts for ultrasound dating of pregnancy and assessment of fetal growth: longitudinal data from a population-based cohort study. Ultrasound Obstet Gynecol. 2008;31(4):388–96. doi:10.1002/uog.5225.
28. Rigby RA, Stasinopoulos DM. Generalized additive models for location, scale and shape. J Royal Stat Soc Ser C (Appl Stat). 2005;54:507–54. doi:10.1111/j.1467-9876.2005.00510.x.
29. Jaddoe VWV, de Jonge LL, Hofman A, Franco OH, Steegers EAP, Gaillard R. First trimester fetal growth restriction and cardiovascular risk factors in school age children: population based cohort study. BMJ. 2014;. doi:10.1136/bmj.g14.
30. Mook-Kanamori DO, Steegers EAP, Eilers PH, Raat H, Hofman A, Jaddoe VWV. risk factors and outcomes associated with first-trimester fetal growth restriction. JAMA. 2010;303(6):527–34. doi:10.1001/Jama.2010.78.
31. Medici M, Timmermans S, Visser W, et al. Maternal thyroid hormone parameters during early pregnancy and birth weight: the Generation R Study. J Clin Endocr Metab. 2013;98(1):59–66. doi:10.1210/Jc.2012-2420.
32. Korevaar TIM, Schalekamp-Timmermans S, de Rijke YB, et al. Hypothyroxinemia and TPO-antibody positivity are risk factors for premature delivery: the Generation R Study. J Clin Endocr Metab. 2013;98(11):4382–90. doi:10.1210/Jc.2013-2855.
33. Gaillard R, Steegers EAP, Hofman A, Jaddoe VWV. Associations of maternal obesity with blood pressure and the risks of gestational hypertensive disorders: the Generation R Study. J Hypertens. 2011;29(5):937–44. doi:10.1097/Hjh.0b013e328345500c.
34. Sterne JA, White IR, Carlin JB, et al. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ. 2009;338:b2393. doi:10.1136/bmj.b2393.
35. Tanaka M, Natori M, Kohno H, Ishimoto H, Kobayashi T, Nozawa S. Fetal growth in patients with elevated maternal serum hCG levels. Obstet Gynecol. 1993;81(3):341–3.
36. Leung TY, Chan LW, Leung TN, Fung TY, Sahota DS, Lau TK. First-trimester maternal serum levels of placental hormones are independent predictors of second-trimester fetal growth parameters. Ultrasound Obstet Gynecol. 2006;27(2):156–61. doi:10.1002/uog.2656.
37. Reynolds TM, Vranken G, Van Nueten J. Weight correction of MoM values: which method? J Clin Pathol. 2006;59(7):753–8. doi:10.1136/jcp.2005.034280.
38. Reisinger K, Baal N, McKinnon T, Munstedt K, Zygmunt M. The gonadotropins: tissue-specific angiogenic factors? Mol Cell Endocrinol. 2007;269(1–2):65–80. doi:10.1016/j.mce.2006.11.015.
39. Sierra-Honigmann MR, Nath AK, Murakami C, et al. Biological action of leptin as an angiogenic factor. Science. 1998;281(5383):1683–6.
40. Rega G, Kaun C, Demyanets S, et al. Vascular endothelial growth factor is induced by the inflammatory cytokines interleukin-6 and oncostatin m in human adipose tissue in vitro and in murine adipose tissue in vivo. Arterioscler Thromb Vasc Biol. 2007;27(7):1587–95. doi:10.1161/ATVBAHA.107.143081.
41. Ball S, Ekelund C, Wright D, et al. Temporal effects of maternal and pregnancy characteristics on serum pregnancy-associated plasma protein-A and free beta-human chorionic gonadotropin at 7–14 weeks’ gestation. Ultrasound Obstet Gynecol. 2013;41(1):33–9. doi:10.1002/uog.11209.
42. Ball S, Wright D, Sodre D, Lachmann R, Nicolaides KH. Temporal effect of Afro-Caribbean race on serum pregnancy-associated plasma protein-a at 9–13 weeks’ gestation in screening for aneuploidies. Fetal Diagn Ther. 2012;31(3):162–9. doi:10.1159/000336252.
43. Bestwick JP, Huttly WJ, Wald NJ. First trimester Down’s syndrome screening marker values and cigarette smoking: new data and a meta-analysis on free beta human chorionic gonadotophin, pregnancy-associated plasma protein-A and nuchal translucency. J Med Screen. 2008;15(4):204–6. doi:10.1258/jms.2008.008049.
44. Vogt Isaksen C. Maternal smoking, intrauterine growth restriction, and placental apoptosis. Pediatr Dev Pathol. 2004;7(5):433–42.
45. Williams LA, Evans SF, Newnham JP. Prospective cohort study of factors influencing the relative weights of the placenta and the newborn infant. BMJ. 1997;314(7098):1864–8.
46. http://labmed.ucsf.edu/labmanual/db/resource/Immulite_2000_HCG.pdf.